Monitor for any prospectus supplement indicating Perceptive's intent to sell. The $1.9314 exercise price is below the recent $2.11 close, giving Perceptive an incentive to exercise and sell. However, the 10-year warrant term reduces urgency. The filing itself is neutral — the real event was the July 30 note purchase.
Price Chart
Executive Summary
Autolus Therapeutics filed an S-3 registration statement to register 3,500,000 ADSs for resale by Perceptive Credit Holdings, issued as a warrant sweetener in a July 30, 2026 note purchase. The filing is a contractual obligation, not a new capital raise by the company. The potential overhang from Perceptive's ability to sell shares at $1.9314 (vs. $2.11 close) creates modest near-term dilution risk, but the company receives no proceeds from the resale. The filing is routine and the dilution is manageable (~1.3% of shares outstanding).
Key Financial Metrics
Key Facts
- Registers 3,500,000 ADSs for resale by Perceptive Credit Holdings V, LP.
- Warrant exercise price is $1.9314 per ADS, expiring July 30, 2036.
- Represents ~1.3% of shares outstanding (266,162,540 as of Aug 10, 2026).
- Company receives no proceeds from the resale; only receives cash if warrant is exercised for cash.
- Filing fulfills contractual obligation under Registration Rights Agreement dated July 30, 2026.
Financial Impact
Potential dilution of ~1.3% of shares outstanding. If all warrants are exercised for cash, company would receive ~$6.76M.
Risk Factors
- Perceptive may sell shares, creating overhang pressure on the stock.
- Warrant can be exercised on a cashless basis, meaning no cash proceeds to the company.
- Company has a history of frequent offerings (10 in 24 months), signaling ongoing capital needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-389586 |
| Document: d112040dex51.htm | 0001193125-26-389586 |
| Document: d112040dexfilingfees.htm | 0001193125-26-389586 |
| Document: d112040dex231.htm | 0001193125-26-389586 |
| Document: 0001193125-26-389586-index-headers.html | 0001193125-26-389586 |
| Document: 0001193125-26-389586-index.html | 0001193125-26-389586 |
| Document: 0001193125-26-389586.txt | 0001193125-26-389586 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 12, 2026 20d ago | S-3 | $1.94 $1.94 | · 0.00% | ▼ −0.11% | $1.78 (−8.25%) |
Aug 11, 2026 7w ago | 8-K | $2.33 $2.29 | ▼ −1.72% | ▼ −1.31% | $1.78 (−23.61%) |
Aug 3, 2026 8w ago | 8-K | $1.82 $2.07 | ▲ +13.74% | ▲ +11.71% | $1.78 (−2.20%) |
Aug 3, 2026 8w ago | 8-K | $1.82 $2.07 | ▲ +13.74% | ▲ +11.71% | $1.78 (−2.20%) |
Jun 12, 2026 16w ago | Press Release | $1.56 $1.51 | ▼ −3.21% | ▼ −3.88% | $1.78 (+14.10%) |
Jun 11, 2026 16w ago | Institutional Cluster | $1.56 $1.53 | ▲ +1.92% | ▲ +2.36% | $1.78 (−14.10%) |
Jun 9, 2026 16w ago | 8-K | $1.46 $1.50 | ▼ −2.74% | ▼ −0.33% | $1.78 (−21.92%) |
May 21, 2026 19w ago | Press Release | $1.70 $1.84 | ▲ +8.24% | ▲ +6.58% | $1.78 (+4.71%) |
May 14, 2026 20w ago | 8-K | $1.59 $1.65 | ▲ +3.77% | ▲ +4.49% | $1.78 (+11.95%) |
May 14, 2026 20w ago | Press Release | $1.59 $1.65 | ▲ +3.77% | ▲ +4.49% | $1.78 (+11.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access